Integrin alpha 4 beta 1 is a major leukocyte adhesion receptor that is a ke
y target for the development of anti-inflammatory therapeutics. With the du
al long-term goals of de, eloping a reagent for use in high-throughput inhi
bitor screening assays and for crystallisation trials and subsequent struct
ure determination, we have generated a recombinant soluble alpha 4 beta 1 r
eceptor, Both subunits were truncated prior to the transmembrane domains by
site-directed mutagenesis and expressed using baculovirus infection of ins
ect cells. The molecular weights of the recombinant subunits were as expect
ed for post-translationally unmodified protein, In addition, as observed fo
r the native subunit, a proportion of the alpha 4 subunit was proteolytical
ly processed into two fragments. ELISA and solid phase ligand-binding assay
s were performed to investigate the folding and functionality of the solubl
e integrin, The data suggest that the receptor was correctly folded and tha
t it bound recombinant ligands,vith similar kinetics to the native molecule
. (C) 2000 Federation of European Biochemical Societies.